drugset / Trial / NCT00450749

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

NCT00450749

Phase 2 Completed 10 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.

Timeline

Start
2008-02
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lycopene Other / unclassified Oral